These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18768987)

  • 1. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha.
    Ramière C; Scholtès C; Diaz O; Icard V; Perrin-Cocon L; Trabaud MA; Lotteau V; André P
    J Virol; 2008 Nov; 82(21):10832-40. PubMed ID: 18768987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily.
    Yu X; Mertz JE
    J Virol; 1997 Dec; 71(12):9366-74. PubMed ID: 9371596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
    Kardassis D; Roussou A; Papakosta P; Boulias K; Talianidis I; Zannis VI
    Biochem J; 2003 Jun; 372(Pt 2):291-304. PubMed ID: 12585964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic sensors FXRα, PGC-1α, and SIRT1 cooperatively regulate hepatitis B virus transcription.
    Curtil C; Enache LS; Radreau P; Dron AG; Scholtès C; Deloire A; Roche D; Lotteau V; André P; Ramière C
    FASEB J; 2014 Mar; 28(3):1454-63. PubMed ID: 24297698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.
    Laffitte BA; Kast HR; Nguyen CM; Zavacki AM; Moore DD; Edwards PA
    J Biol Chem; 2000 Apr; 275(14):10638-47. PubMed ID: 10744760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor-α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo.
    Mouzannar K; Fusil F; Lacombe B; Ollivier A; Ménard C; Lotteau V; Cosset FL; Ramière C; André P
    FASEB J; 2019 Feb; 33(2):2472-2483. PubMed ID: 30307769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.
    Reese VC; Moore DD; McLachlan A
    J Virol; 2012 Mar; 86(5):2760-8. PubMed ID: 22171277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4.
    Lin WJ; Li J; Lee YF; Yeh SD; Altuwaijri S; Ou JH; Chang C
    J Biol Chem; 2003 Mar; 278(11):9353-60. PubMed ID: 12522137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development.
    Reese V; Ondracek C; Rushing C; Li L; Oropeza CE; McLachlan A
    Int J Biochem Cell Biol; 2011 Feb; 43(2):230-7. PubMed ID: 19941970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
    Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
    J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1.
    Gilbert S; Galarneau L; Lamontagne A; Roy S; Bélanger L
    J Virol; 2000 Jun; 74(11):5032-9. PubMed ID: 10799577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators.
    Raney AK; Kline EF; Tang H; McLachlan A
    Virology; 2001 Oct; 289(2):239-51. PubMed ID: 11689047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors.
    Crestani M; Sadeghpour A; Stroup D; Galli G; Chiang JY
    J Lipid Res; 1998 Nov; 39(11):2192-200. PubMed ID: 9799805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.
    Urizar NL; Dowhan DH; Moore DD
    J Biol Chem; 2000 Dec; 275(50):39313-7. PubMed ID: 10998425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FXRalpha down-regulates LXRalpha signaling at the CETP promoter via a common element.
    Park SS; Choi H; Kim SJ; Kim OJ; Chae KS; Kim E
    Mol Cells; 2008 Oct; 26(4):409-14. PubMed ID: 18562803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.
    Choi BH; Park GT; Rho HM
    J Biol Chem; 1999 Jan; 274(5):2858-65. PubMed ID: 9915821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
    Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
    J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by the small heterodimer partner.
    Oropeza CE; Li L; McLachlan A
    J Virol; 2008 Apr; 82(8):3814-21. PubMed ID: 18234786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.
    Lavrentiadou SN; Hadzopoulou-Cladaras M; Kardassis D; Zannis VI
    Biochemistry; 1999 Jan; 38(3):964-75. PubMed ID: 9893992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.